COMPANY OVERVIEW

Athira, headquartered in Seattle, Washington, is a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases like Alzheimer’s and Parkinson’s.

---

LOCATION

Seattle, WA, USA

---

THERAPEUTIC AREAS

Neurodegenerative Disease

---

WEBSITE

https://athira.com

---

CAREER WEBSITE

https://athira.com/team-2/#careers

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jun 4, 2020

Athira Pharma Closes $85 Million Series B Financing

Dec 9, 2019

Athira Pharma Presents Positive Data for NDX-1017 in Alzheimer's Patients at 2019 Clinical Trials on Alzheimer's Disease (CTAD) Conference

Nov 20, 2019

Athira Pharma to Present Phase 1 Data for NDX-1017 in Oral Presentation at 2019 Clinical Trials on Alzheimer's Disease (CTAD) Conference

Oct 2, 2019

Athira Pharma Announces Completion of Phase 1b Clinical Trial of NDX-1017 in Alzheimer's Patients

Jul 16, 2019

Athira Pharma Presents Preliminary Results from Phase 1 Trial of NDX-1017 at Alzheimer's Association International Conference 2019 (AAIC)

For More Press Releases

---